Background:
Natural products, such as phenylpropanoids, which are found in essential oils derived from aromatic plants, have been explored during non-clinical psychopharmacology studies, to discover new molecules with relevant pharmacological activities in the central nervous system, especially antidepressant and anxiolytic activities. Major
depressive disorder is a highly debilitating psychiatric disorder and is considered to be a disabling public health problem,
worldwide, as a primary factor associated with suicide. Current clinically administered antidepressants have late-onset
therapeutic actions, are associated with several side effects, and clinical studies have reported that some patients do not respond well to treatment or reach complete remission.
Objective:
To review important new targets for antidepressant activity and to select phenylpropanoids with antidepressant
activity, using Molegro Virtual Docker and Ossis Data Warris, and to verify substances with more promising antidepressant activity.
Results and Conclusion:
We conducted an in silico molecular modeling study, based on homology, to determine the
three-dimensional structure the 5-hydroxytryptamine 2A receptor (5-HT2AR), then performed molecular docking studies
and examined the predisposition for cytotoxicity risk among identified molecules. We obtained a model for 5-HT2AR
homology, with satisfactory results, indicating the good stereochemical quality of the model. The phenylpropanoid 4-
allyl-2,6-dimethoxyphenol showed the lowest binding energy for 5-HT2AR, with results relevant to the L-arginine/nitric
oxide (NO)/cGMP pathway, and showed no toxicity within the parameters of mutagenicity, carcinogenicity, reproductive
system toxicity, and skin-tissue irritability, when evaluated in silico; therefore, this molecule can be considered promising
for the investigation of antidepressant activity.